BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.02% | 21.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.02% | 21.98% | |||
| Cost of Revenue | -22.88% | 24.96% | |||
| Gross Profit | -16.19% | 20.90% | |||
| SG&A Expenses | -14.43% | 33.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.55% | 31.51% | |||
| Operating Income | -19.24% | 2.80% | |||
| Income Before Tax | -21.50% | 19.59% | |||
| Income Tax Expenses | -12.22% | 14.36% | |||
| Earnings from Continuing Operations | -23.88% | 21.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.88% | 21.01% | |||
| EBIT | -19.24% | 2.80% | |||
| EBITDA | -18.21% | 3.16% | |||
| EPS Basic | -23.80% | 21.00% | |||
| Normalized Basic EPS | -19.55% | 17.47% | |||
| EPS Diluted | -24.03% | 21.32% | |||
| Normalized Diluted EPS | -19.55% | 17.47% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||